ライフサイエンスコーパス: cationic antimicrobial peptide

1 se of colistin has led to resistance to this cationic antimicrobial peptide.

2 sium limitation, low pH, and the presence of cationic antimicrobial peptides.

3 cated as a resistance mechanism specific for cationic antimicrobial peptides.

4 idation of membrane-binding peptides such as cationic antimicrobial peptides.

5 gest a functional mechanism akin to that for cationic antimicrobial peptides.

6 system can sense sublethal concentrations of cationic antimicrobial peptides.

7 is required for resistance to polymyxin and cationic antimicrobial peptides.

8 is gene was designated rcp for resistance to cationic antimicrobial peptides.

9 re important for virulence and resistance to cationic antimicrobial peptides.

10 rabinose modification promotes resistance to cationic antimicrobial peptides.

11 phage phagosomes necessary for resistance to cationic antimicrobial peptides.

12 membrane stability and provide resistance to cationic antimicrobial peptides.

13 odel and on the organism's susceptibility to cationic antimicrobial peptides.

14 nhanced ExPortal integrity and resistance to cationic antimicrobial peptides.

15 one structure can provide protection against cationic antimicrobial peptides.

16 s, combined with an increased sensitivity to cationic antimicrobial peptides.

17 d less susceptible to focal targeting by the cationic antimicrobial peptides.

18 medium and stimulated by low pH and certain cationic antimicrobial peptides.

19 mediated by Toll-like receptor 4 (TLR4) and cationic antimicrobial peptides.

20 ycerols, which is critical for resistance to cationic antimicrobial peptides.

21 tem responds to low extracellular Mg(++) and cationic antimicrobial peptides.

22 ide binding and the observed specificity for cationic antimicrobial peptides.

23 PhoQ also binds and is activated by cationic antimicrobial peptides.

24 ounters in the host, including attack by the cationic antimicrobial peptides.

25 at might be important in the inactivation of cationic antimicrobial peptides.

26 saccharide, thereby lowering its affinity to cationic antimicrobial peptides.

27 gainin 2 and PGLa are among the best-studied cationic antimicrobial peptides.

28 are required for virulence and resistance to cationic antimicrobial peptides.

29 oxidative stress but remained vulnerable to cationic antimicrobial peptides.

30 LL-37/human cationic antimicrobial peptide 18 (hCAP18) is a human ca

31 ression promoted resistance to alpha-helical cationic antimicrobial peptides (alpha-CAMPs).

32 Indolicidin is a 13-residue cationic, antimicrobial peptide-amide isolated from the

33 Several cationic antimicrobial peptides (AMPs) have recently bee

34 significantly more susceptible to killing by cationic antimicrobial peptides (AMPs) of the cathelicid

35 have shown that activation of the system by cationic antimicrobial peptides (AMPs) results, among ot

36 defensins (hBDs) are epithelial cell-derived cationic antimicrobial peptides (AMPs) that also functio

37 ar survival by increasing resistance to host cationic antimicrobial peptides and decreasing host cell

38 arabinose were associated with resistance to cationic antimicrobial peptides and increased inflammato

39 uld also provide necessary binding sites for cationic antimicrobial peptides and proteins (CAMPs).

40 pathogens, providing resistance to both host cationic antimicrobial peptides and therapeutic antibiot

41 Gram-negative bacteria to resist killing by cationic antimicrobial peptides and to avoid eliciting a

42 increased resistance to aminoglycosides and cationic antimicrobial peptides, and decreased resistanc

43 mrB confers resistance of Salmonella spp. to cationic antimicrobial peptides (AP) such as polymyxin (

44 Cationic antimicrobial peptides (APs) are produced at mu

45 Linear cationic antimicrobial peptides are a diverse class of m

46 In both of these niches, cationic antimicrobial peptides are an essential compone

47 Human alpha-defensins, small cationic antimicrobial peptides, are found in neutrophil

48 A group of short cationic antimicrobial peptides, called cathelicidins, h

49 Colistin is a cationic antimicrobial peptide (CAMP) antibiotic that pe

50 nvestigated the function of ToxR and LeuO in cationic antimicrobial peptide (CAMP) resistance.

51 rulence regulators induce resistance to host cationic antimicrobial peptides (CAMP) after infection o

52 Cationic antimicrobial peptides (CAMP) represent a conse

53 sed endotoxicity and decreased resistance to cationic antimicrobial peptides (CAMP).

54 of acidic pH, limited divalent cations, and cationic antimicrobial peptides (CAMP).

55 Cationic antimicrobial peptides (CAMPs) and photodynamic

56 Cationic antimicrobial peptides (CAMPs) are important co

57 To the contrary, the repulsion of cationic antimicrobial peptides (CAMPs) is attributed to

58 ith innate defenses within the host, such as cationic antimicrobial peptides (CAMPs) produced by the

59 a common strategy used by bacteria to resist cationic antimicrobial peptides (CAMPs) secreted by othe

60 nce to complement-mediated bacteriolysis and cationic antimicrobial peptides (CAMPs), and recently we

61 Such stresses include amphipathic cationic antimicrobial peptides (CAMPs), and resistance

62 s in their resistance to membrane disrupting cationic antimicrobial peptides (CAMPs), such as polymyx

63 Cationic antimicrobial peptides (CAMPs), such as polymyx

64 e small peptides (<10 kDa) that included two cationic antimicrobial peptides (CAMPs), the rat catheli

65 es resistance to the bactericidal effects of cationic antimicrobial peptides (CAMPs).

66 a barrier to toxic molecules, including host cationic antimicrobial peptides (CAMPs).

67 lling by host innate immune factors, such as cationic antimicrobial peptides (CAMPs).

68 ystem contributes to bacterial resistance to cationic antimicrobial peptides (CAMPs).

69 ubstrates, the role of BrlR in resistance to cationic antimicrobial peptides (CAP), which is based on

70 al membrane, emerging research suggests that cationic antimicrobial peptides (CAPs) can influence pat

71 Cationic antimicrobial peptides (CAPs) occur as importan

72 Cationic antimicrobial peptides (CAPs) such as defensins

73 o be involved in staphylococcal responses to cationic antimicrobial peptides (CAPs).

74 Defensins are cysteine-rich cationic antimicrobial peptides contributing to the inna

75 Hence, and in contrast to the cationic antimicrobial peptide described in the followin

76 known that the microbicidal actions of other cationic antimicrobial peptides (e.g., neutrophil defens

77 Mammalian defensins are small, cationic, antimicrobial peptides encoded by the host tha

78 beta-Defensins are cationic antimicrobial peptides expressed in epithelia.

79 The minimum inhibitory concentration of cationic antimicrobial peptides for the two strains was

80 -3 are three members of the family of linear cationic antimicrobial peptides found in tree frogs.

81 deficient mutant that is highly sensitive to cationic antimicrobial peptides had a normal phenotype i

82 ) limitation, acidic pH, and the presence of cationic antimicrobial peptides have been identified as

83 Several cationic antimicrobial peptides have been investigated a

84 emokine, human beta-defensin-1 and -2, small cationic antimicrobial peptides, have also been found to

85 sistance to killing by distinct host defense cationic antimicrobial peptides (HD-CAPs).

86 almitoylation commonly confers resistance to cationic antimicrobial peptides, however, increased cyto

87 is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and

88 is required for resistance to polymyxin and cationic antimicrobial peptides in Escherichia coli and

89 esses a mechanism that induces resistance to cationic antimicrobial peptides in response to environme

90 B blood and was more sensitive to killing by cationic antimicrobial peptides including moronecidin fr

91 riptional regulator and confer resistance to cationic antimicrobial peptides, including polymyxin.

92 ocidal activities demonstrated that CRAMP, a cationic antimicrobial peptide, is primarily responsible

93 Our results demonstrate that the cationic antimicrobial peptide LL37 converts self-RNA in

94 in the skin of psoriasis patients, the human cationic antimicrobial peptide LL37 is highly expressed

95 skin, these barriers can be breached by the cationic antimicrobial peptide LL37.

96 esign of human beta-defensin-2, a 41-residue cationic antimicrobial peptide of the innate immune syst

97 Because alpha-defensins, which are cationic antimicrobial peptides of polymorphonuclear neu

98 Such modification results in resistance to cationic antimicrobial peptides of the innate immune sys

99 ted in bacterial resistance to polymyxin and cationic antimicrobial peptides of the innate immune sys

100 n increased sensitivity to both colistin and cationic antimicrobial peptides of the innate immune sys

101 hanisms to resist the bactericidal action of cationic antimicrobial peptides of the innate immune sys

102 nst Gram-negative bacteria, the binding to a cationic antimicrobial peptide offers the attractive pro

103 When these interactions are disrupted by cationic antimicrobial peptides, or by the loss of negat

104 n strain showed increased sensitivity to the cationic antimicrobial peptide polymyxin as well as bile

105 al membrane resulting in protection from the cationic antimicrobial peptide polymyxin B.

106 ovicida mutant was highly susceptible to the cationic antimicrobial peptide polymyxin.

107 occal resistance to two structurally diverse cationic antimicrobial peptides (polymyxin B and LL-37)

108 wed a 20-fold increase in sensitivity to the cationic antimicrobial peptide, polymyxin B, as well as

109 um lipid A is required for resistance to the cationic antimicrobial peptide, polymyxin.

110 ant to human beta-defensins, which are small cationic antimicrobial peptides produced by a number of

111 y pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate i

112 elet microbicidal protein (tPMP) is a small, cationic, antimicrobial peptide released from rabbit pla

113 vity produced two phenotypes associated with cationic antimicrobial peptide resistance and O-antigen

114 Because of their role in cationic antimicrobial peptide resistance, we propose th

115 o separate networks of genes responsible for cationic antimicrobial peptide resistance.

116 of the bacterial surface, thereby promoting cationic antimicrobial peptide resistance.

117 ned the significance of LpxE with respect to cationic antimicrobial peptide resistance.

118 Human beta-defensins (hBDs) are small, cationic antimicrobial peptides, secreted by mucosal epi

119 ting arnT decreased resistance to killing by cationic antimicrobial peptides, such as polymyxin B and

120 to H(2)O(2) but resistant to LL-37, a human cationic antimicrobial peptide, suggests an inherent res

121 hate groups of lipid A aids in resistance to cationic antimicrobial peptides targeting the bacterial

122 fish epithelial cells and more resistant to cationic antimicrobial peptides than wild-type S. iniae.

123 Epithelial beta-defensins are broad-spectrum cationic antimicrobial peptides that also act as chemoki

124 The human beta-defensins are small, cationic antimicrobial peptides that are made by epithel

125 Human neutrophil alpha-defensins (HNPs) are cationic antimicrobial peptides that are synthesized in

126 Defensins are cationic antimicrobial peptides that have a characterist

127 Type A (I) lantibiotics are cationic antimicrobial peptides that have a potential us

128 1 (hBD-1) is a member of the family of small cationic antimicrobial peptides that have been identifie

129 t of this system is a diverse combination of cationic antimicrobial peptides that include the alpha-

130 Mammalian defensins are cationic antimicrobial peptides that play a central role

131 nstitute an evolutionary conserved family of cationic antimicrobial peptides that play a key role in

132 Defensins are cationic antimicrobial peptides that serve as important

133 ic insights into the mode-of-action of small cationic antimicrobial peptides that should facilitate i

134 ense peptides distinct from another class of cationic antimicrobial peptides, the defensins.

135 murium regulates mechanisms of resistance to cationic antimicrobial peptides through the two-componen

136 Different from classic cationic antimicrobial peptides usually with high cation

137 yamines to increase gonococcal resistance to cationic antimicrobial peptides was dose dependent, corr

138 ging reasons; DeltavisP is less resistant to cationic antimicrobial peptides, whereas DeltalpxO is de

139 Piscidin belongs to a family of amphipatic cationic antimicrobial peptides, which are membrane-acti